About the Authors
- Jian Luo
-
Contributed equally to this work with: Jian Luo, Gayathri Swaminath
Affiliation Department of Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America
- Gayathri Swaminath
-
Contributed equally to this work with: Jian Luo, Gayathri Swaminath
Affiliation Department of Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America
- Sean P. Brown
-
Affiliation Department of Therapeutic Discovery, Amgen Inc., South San Francisco, California, United States of America
- Jane Zhang
-
Affiliation Department of Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America
- Qi Guo
-
Affiliation Department of Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America
- Michael Chen
-
Affiliation Department of Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America
- Kathy Nguyen
-
Affiliation Department of Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America
- Thanhvien Tran
-
Affiliation Department of Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America
- Lynn Miao
-
Affiliation Department of Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America
- Paul J. Dransfield
-
Affiliation Department of Therapeutic Discovery, Amgen Inc., South San Francisco, California, United States of America
- Marc Vimolratana
-
Affiliation Department of Therapeutic Discovery, Amgen Inc., South San Francisco, California, United States of America
- Jonathan B. Houze
-
Affiliation Department of Therapeutic Discovery, Amgen Inc., South San Francisco, California, United States of America
- Simon Wong
-
Affiliation Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., South San Francisco, California, United States of America
- Maria Toteva
-
Affiliation Department of Pharmaceutics, Amgen Inc., South San Francisco, California, United States of America
- Bei Shan
-
Affiliation Department of Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America
- Frank Li
-
Affiliation Department of Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America
- Run Zhuang
-
Affiliation Department of Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America
- Daniel C.-H. Lin
-
* E-mail: dclin@amgen.com
Affiliation Department of Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America
Competing Interests
All authors were employed by and shareholders in Amgen during the study period. Patents filed or issued: U.S. Patent No. 7,649,110, U.S. Patent No. 7,816,367, U.S. Patent No. 8,030,354 and WO 2005/086661. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: JL GS SPB PJD SW MT DCHL. Performed the experiments: GS SPB JZ QG MC KN TT LM PJD MV MT FL RZ DCHL. Analyzed the data: JL GS SPB PJD JBH SW MT BS DCHL. Contributed reagents/materials/analysis tools: SPB PJD. Wrote the paper: SPB DCHL.